Clinical Trial

Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis

Terminated Phase 2
View on ClinicalTrials.gov →
Why the trial stopped
The main objective of this study has been achieved. Following internal discussions, the sponsor has decided to terminate this study early.
Summary
Compare the diagnostic certainty of MIBI SPECT myocardial perfusion imaging (MPI) and XTR004 PET MPI.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-16.
Trial Details
NCT Number NCT07187895
Lead Sponsor Sinotau Pharmaceutical Group
Conditions Myocardial Perfusion Imaging, Diagnostic Certainty, Stable Coronary Artery Disease
Enrollment 17 participants
Start Date 2024-12-19
Primary Completion 2025-03-05 (estimated)
Study Completion 2025-03-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-12